newsfilter
← Latest News
GlobeNewswire·

Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research

SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a biopharmaceutical company with a sole focus of closing the gap in women's health between promising science and real solutions,